Riskpilot← Back to searchSign inGet full accessCerealiq AB
ABActiveOrg 5591694301Södra Vägen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20183 employees
Revenue 2025
SEK 21,6M
+2% vs 2024
EBITDA margin
14.3%
-9% vs 2024
Equity ratio
51.8%
Financial strength
Net profit 2025
SEK 1,8M
-10% vs 2024
| Revenue | SEK 21,6M | +2% |
| EBITDA | SEK 3,1M | -9% |
| Net profit | SEK 1,8M | -10% |
| Total assets | SEK 9,6M | +16% |
| Equity | SEK 5M | +6% |
| Employees | 3 | — |
Legal name
Cerealiq AB
Org number
5591694301
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 augusti 2018
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamheten sysslar med utveckling och rådgivning gällande växtbaserade drycker och försäljning av insatsvaror för tillverkning av dessa drycker och därmed förenlig verksamhet.
Address
Södra Vägen 2
Phone
+46704803223
Email
emilie@cerealiq.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 573 | 9 912 | 12 992 | 21 255 | 21 613 |
| Staff expenses | — | −584 | −1 164 | −1 561 | −2 660 |
| EBITDA | 1 865 | 1 902 | 1 025 | 3 389 | 3 087 |
| Depreciation & amort. | −0 | −36 | −36 | −69 | −79 |
| EBIT | 1 865 | 1 866 | 989 | 3 320 | 3 009 |
| Net financials | −3 | −17 | −4 | 11 | 4 |
| Profit before tax | 1 412 | 1 381 | 735 | 2 523 | 2 268 |
| Tax | −292 | −289 | −162 | −532 | −481 |
| Net profit | 1 120 | 1 092 | 573 | 1 991 | 1 787 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 688 | 5 050 | 5 490 | 8 332 | 9 645 |
| Equity | 1 957 | 3 049 | 2 723 | 4 714 | 5 001 |
| Long-term debt | 300 | 0 | — | — | — |
| Short-term debt | 766 | 868 | 1 385 | 1 428 | 1 709 |
| Total debt | 1 066 | 868 | 1 385 | 1 428 | 1 709 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
51.8%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
35.7%
This company
18.4%
Market median
+94% vs market
20212025
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20212025
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
20212025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC Chief Executive Officer | Chief Executive Officer | 2025 |
LY Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cerealiq AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emilie Cecilia Sellman | Chief Executive Officer | 0 companies |
| Lotta Y S C Hansen | Audit | 0 companies |
| Angeliki Öste Triantafyllou | Chairman | 0 companies |
| Berit Ann-Sofie Lingefelt Karlsson | Deputy Board Member | 0 companies |
| Mats Tage Håkan Karlsson | Board of Directors | 0 companies |